These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 15251137)

  • 1. Regulatory T cells.
    Thompson C; Powrie F
    Curr Opin Pharmacol; 2004 Aug; 4(4):408-14. PubMed ID: 15251137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulatory T cells generated ex vivo as an approach for the therapy of autoimmune disease.
    Horwitz DA; Zheng SG; Gray JD; Wang JH; Ohtsuka K; Yamagiwa S
    Semin Immunol; 2004 Apr; 16(2):135-43. PubMed ID: 15036237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An immunomodulatory role for CD4(+)CD25(+) regulatory T lymphocytes in hepatitis C virus infection.
    Cabrera R; Tu Z; Xu Y; Firpi RJ; Rosen HR; Liu C; Nelson DR
    Hepatology; 2004 Nov; 40(5):1062-71. PubMed ID: 15486925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complementary role of CD4+CD25+ regulatory T cells and TGF-beta in oral tolerance.
    Chung Y; Lee SH; Kim DH; Kang CY
    J Leukoc Biol; 2005 Jun; 77(6):906-13. PubMed ID: 15758078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Control of Foxp3+ CD25+CD4+ regulatory cell activation and function by dendritic cells.
    Fehérvári Z; Sakaguchi S
    Int Immunol; 2004 Dec; 16(12):1769-80. PubMed ID: 15520045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crucial role of FOXP3 in the development and function of human CD25+CD4+ regulatory T cells.
    Yagi H; Nomura T; Nakamura K; Yamazaki S; Kitawaki T; Hori S; Maeda M; Onodera M; Uchiyama T; Fujii S; Sakaguchi S
    Int Immunol; 2004 Nov; 16(11):1643-56. PubMed ID: 15466453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ex vivo activated OVA specific and non-specific CD4+CD25+ regulatory T cells exhibit comparable suppression to OVA mediated T cell responses.
    Li J; Bracht M; Shang X; Radewonuk J; Emmell E; Griswold DE; Li L
    Cell Immunol; 2006 Jun; 241(2):75-84. PubMed ID: 17010326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acquisition of anergic and suppressive activities in transforming growth factor-beta-costimulated CD4+CD25- T cells.
    Park HB; Paik DJ; Jang E; Hong S; Youn J
    Int Immunol; 2004 Aug; 16(8):1203-13. PubMed ID: 15237111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease.
    Sakaguchi S; Ono M; Setoguchi R; Yagi H; Hori S; Fehervari Z; Shimizu J; Takahashi T; Nomura T
    Immunol Rev; 2006 Aug; 212():8-27. PubMed ID: 16903903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Augmented induction of CD4+CD25+ Treg using monoclonal antibodies to CD200R.
    Gorczynski RM; Lee L; Boudakov I
    Transplantation; 2005 Feb; 79(4):488-91. PubMed ID: 15729177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tr1 and naturally occurring regulatory T cells induce IgG4 in B cells through GITR/GITR-L interaction, IL-10 and TGF-beta.
    Satoguina JS; Adjobimey T; Arndts K; Hoch J; Oldenburg J; Layland LE; Hoerauf A
    Eur J Immunol; 2008 Nov; 38(11):3101-13. PubMed ID: 18924213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retroviral delivery of GAD-IgG fusion construct induces tolerance and modulates diabetes: a role for CD4+ regulatory T cells and TGF-beta?
    Song L; Wang J; Wang R; Yu M; Sun Y; Han G; Li Y; Qian J; Scott DW; Kang Y; Soukhareva N; Shen B
    Gene Ther; 2004 Oct; 11(20):1487-96. PubMed ID: 15343360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of human CD4+ cells with CD3 and CD46 induces a T-regulatory cell 1 phenotype.
    Kemper C; Chan AC; Green JM; Brett KA; Murphy KM; Atkinson JP
    Nature; 2003 Jan; 421(6921):388-92. PubMed ID: 12540904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In-vitro generation and characterisation of murine CD4+CD25+ regulatory T cells with indirect allospecificity.
    Tsang J; Jiang S; Tanriver Y; Leung E; Lombardi G; Lechler RI
    Int Immunopharmacol; 2006 Dec; 6(13-14):1883-8. PubMed ID: 17161341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antigen-specific regulatory T cells--their induction and role in infection.
    Mills KH; McGuirk P
    Semin Immunol; 2004 Apr; 16(2):107-17. PubMed ID: 15036234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overlap between molecular markers expressed by naturally occurring CD4+CD25+ regulatory T cells and antigen specific CD4+CD25+ and CD8+CD28- T suppressor cells.
    Scotto L; Naiyer AJ; Galluzzo S; Rossi P; Manavalan JS; Kim-Schulze S; Fang J; Favera RD; Cortesini R; Suciu-Foca N
    Hum Immunol; 2004 Nov; 65(11):1297-306. PubMed ID: 15556680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD4CD25 regulatory T lymphocytes in allergy and asthma.
    Shi HZ; Qin XJ
    Allergy; 2005 Aug; 60(8):986-95. PubMed ID: 15969678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene expression analysis of the CD4+ T-cell clones derived from gingival tissues of periodontitis patients.
    Ito H; Honda T; Domon H; Oda T; Okui T; Amanuma R; Nakajima T; Yamazaki K
    Oral Microbiol Immunol; 2005 Dec; 20(6):382-6. PubMed ID: 16238600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TGF-beta1 production by CD4+ CD25+ regulatory T cells is not essential for suppression of intestinal inflammation.
    Kullberg MC; Hay V; Cheever AW; Mamura M; Sher A; Letterio JJ; Shevach EM; Piccirillo CA
    Eur J Immunol; 2005 Oct; 35(10):2886-95. PubMed ID: 16180248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Type 1 T-regulatory cells: their role in the control of immune responses.
    Groux H
    Transplantation; 2003 May; 75(9 Suppl):8S-12S. PubMed ID: 12819483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.